NSN 6505-01-159-9250 · NIIN 011599250 · FSC 6505
NO DASHES 6505011599250
In Stock
THEOPHYLLINE EXTENDED-RELEASE TA
Drugs and Biologicals
Technical characteristics
6 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT 300.000 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | TABLETS 100.000 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT |
| FEAT | SPECIAL FEATURES | ANHYDROUS |
| THPE | THERAPEUTIC EQUIVALENT | QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL |
Cross-references
3 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| QUIBRON-T/SR | 29398 |
| NDC61570-0019-01 | 09GL2 |
| NDC00087-0519-41 | 13811 |